These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model. Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969 [TBL] [Abstract][Full Text] [Related]
3. Triple Therapy of HER2 Zolata H; Afarideh H; Davani FA Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759 [TBL] [Abstract][Full Text] [Related]
4. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles. Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160 [TBL] [Abstract][Full Text] [Related]
5. Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer. Gavilán H; Avugadda SK; Fernández-Cabada T; Soni N; Cassani M; Mai BT; Chantrell R; Pellegrino T Chem Soc Rev; 2021 Oct; 50(20):11614-11667. PubMed ID: 34661212 [TBL] [Abstract][Full Text] [Related]
6. Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia. Zhang J; Dewilde AH; Chinn P; Foreman A; Barry S; Kanne D; Braunhut SJ Int J Hyperthermia; 2011; 27(7):682-97. PubMed ID: 21992561 [TBL] [Abstract][Full Text] [Related]
7. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with Cędrowska E; Pruszyński M; Gawęda W; Żuk M; Krysiński P; Bruchertseifer F; Morgenstern A; Karageorgou MA; Bouziotis P; Bilewicz A Molecules; 2020 Feb; 25(5):. PubMed ID: 32106568 [TBL] [Abstract][Full Text] [Related]
8. N-Hydroxysuccinamide functionalized iron oxide nanoparticles conjugated with 5-flurouracil for hyperthermic therapy of malignant liver cancer cells by DNA repair disruption. Veeramani S; Chandrababu L; Rajangam I; Singh NR; Al-Humaid L; Al-Dahmash ND; Balaji R; Chandrasekar N; Hwang MT Int J Biol Macromol; 2023 Oct; 250():126001. PubMed ID: 37532190 [TBL] [Abstract][Full Text] [Related]
9. Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles. Kalber TL; Ordidge KL; Southern P; Loebinger MR; Kyrtatos PG; Pankhurst QA; Lythgoe MF; Janes SM Int J Nanomedicine; 2016; 11():1973-83. PubMed ID: 27274229 [TBL] [Abstract][Full Text] [Related]
10. Magnetothermoacoustics from magnetic nanoparticles by short bursting or frequency chirped alternating magnetic field: a theoretical feasibility analysis. Piao D; Towner RA; Smith N; Chen WR Med Phys; 2013 Jun; 40(6):063301. PubMed ID: 23718611 [TBL] [Abstract][Full Text] [Related]
11. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles. Chauhan A; Midha S; Kumar R; Meena R; Singh P; Jha SK; Kuanr BK Biomater Sci; 2021 Apr; 9(8):2972-2990. PubMed ID: 33635305 [TBL] [Abstract][Full Text] [Related]
12. Selective Magnetic Nanoheating: Combining Iron Oxide Nanoparticles for Multi-Hot-Spot Induction and Sequential Regulation. Ovejero JG; Armenia I; Serantes D; Veintemillas-Verdaguer S; Zeballos N; López-Gallego F; Grüttner C; de la Fuente JM; Puerto Morales MD; Grazu V Nano Lett; 2021 Sep; 21(17):7213-7220. PubMed ID: 34410726 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model. Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy. Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205 [TBL] [Abstract][Full Text] [Related]
15. In Vitro Study of Tumor-Homing Peptide-Modified Magnetic Nanoparticles for Magnetic Hyperthermia. Zhou S; Tsutsumiuchi K; Imai R; Miki Y; Kondo A; Nakagawa H; Watanabe K; Ohtsuki T Molecules; 2024 Jun; 29(11):. PubMed ID: 38893510 [TBL] [Abstract][Full Text] [Related]
16. Gharibkandi NA; Żuk M; Muftuler FZB; Wawrowicz K; Żelechowska-Matysiak K; Bilewicz A Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982357 [TBL] [Abstract][Full Text] [Related]
17. Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells. Truffi M; Colombo M; Sorrentino L; Pandolfi L; Mazzucchelli S; Pappalardo F; Pacini C; Allevi R; Bonizzi A; Corsi F; Prosperi D Sci Rep; 2018 Apr; 8(1):6563. PubMed ID: 29700387 [TBL] [Abstract][Full Text] [Related]
18. Iron Nanoparticles for Low-Power Local Magnetic Hyperthermia in Combination with Immune Checkpoint Blockade for Systemic Antitumor Therapy. Chao Y; Chen G; Liang C; Xu J; Dong Z; Han X; Wang C; Liu Z Nano Lett; 2019 Jul; 19(7):4287-4296. PubMed ID: 31132270 [TBL] [Abstract][Full Text] [Related]
19. Magnetothermal Control of Temperature-Sensitive Repressors in Superparamagnetic Iron Nanoparticle-Coated Greeson EM; Madsen CS; Makela AV; Contag CH ACS Nano; 2022 Oct; 16(10):16699-16712. PubMed ID: 36200984 [TBL] [Abstract][Full Text] [Related]
20. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study. Balivada S; Rachakatla RS; Wang H; Samarakoon TN; Dani RK; Pyle M; Kroh FO; Walker B; Leaym X; Koper OB; Tamura M; Chikan V; Bossmann SH; Troyer DL BMC Cancer; 2010 Mar; 10():119. PubMed ID: 20350328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]